A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 1,105,292 shares of AMGN stock, worth $318 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
1,105,292
Previous 1,032,805 7.02%
Holding current value
$318 Million
Previous $323 Million 10.36%
% of portfolio
0.39%
Previous 0.4%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$309.38 - $337.38 $22.4 Million - $24.5 Million
72,487 Added 7.02%
1,105,292 $356 Million
Q2 2024

Aug 12, 2024

BUY
$262.75 - $319.31 $32.7 Million - $39.7 Million
124,267 Added 13.68%
1,032,805 $323 Million
Q1 2024

May 09, 2024

BUY
$268.87 - $324.56 $33 Million - $39.8 Million
122,722 Added 15.62%
908,538 $258 Million
Q4 2023

Feb 08, 2024

BUY
$255.7 - $288.46 $9.08 Million - $10.2 Million
35,492 Added 4.73%
785,816 $226 Million
Q3 2023

Nov 07, 2023

BUY
$218.65 - $271.46 $10.3 Million - $12.8 Million
47,128 Added 6.7%
750,324 $202 Million
Q2 2023

Aug 09, 2023

BUY
$214.27 - $253.37 $1.61 Million - $1.9 Million
7,515 Added 1.08%
703,196 $156 Million
Q1 2023

May 08, 2023

BUY
$225.79 - $275.2 $11.1 Million - $13.5 Million
49,152 Added 7.6%
695,681 $168 Million
Q4 2022

Feb 07, 2023

BUY
$229.03 - $291.01 $12.4 Million - $15.7 Million
53,924 Added 9.1%
646,529 $170 Million
Q3 2022

Nov 01, 2022

BUY
$224.46 - $253.15 $8.64 Million - $9.74 Million
38,472 Added 6.94%
592,605 $134 Million
Q2 2022

Aug 04, 2022

BUY
$230.71 - $256.74 $35.6 Million - $39.6 Million
154,342 Added 38.61%
554,133 $135 Million
Q1 2022

May 09, 2022

BUY
$219.27 - $242.57 $6.89 Million - $7.63 Million
31,442 Added 8.54%
399,791 $96.7 Million
Q4 2021

Feb 07, 2022

BUY
$198.88 - $227.6 $9.12 Million - $10.4 Million
45,841 Added 14.21%
368,349 $83.5 Million
Q3 2021

Nov 04, 2021

BUY
$212.27 - $248.7 $6.59 Million - $7.72 Million
31,046 Added 10.65%
322,508 $68.6 Million
Q2 2021

Aug 06, 2021

BUY
$233.58 - $259.14 $6.86 Million - $7.61 Million
29,350 Added 11.2%
291,462 $71 Million
Q1 2021

May 06, 2021

BUY
$221.91 - $258.6 $5.07 Million - $5.91 Million
22,860 Added 9.55%
262,112 $65.2 Million
Q4 2020

Feb 09, 2021

SELL
$216.38 - $257.67 $18.9 Million - $22.5 Million
-87,429 Reduced 26.76%
239,252 $55 Million
Q3 2020

Nov 10, 2020

BUY
$234.65 - $260.95 $43.5 Million - $48.3 Million
185,222 Added 130.94%
326,681 $83 Million
Q2 2020

Aug 06, 2020

BUY
$197.81 - $242.74 $2.02 Million - $2.48 Million
10,228 Added 7.79%
141,459 $33.4 Million
Q1 2020

May 11, 2020

SELL
$182.24 - $241.7 $1.21 Million - $1.6 Million
-6,614 Reduced 4.8%
131,231 $26.6 Million
Q4 2019

Feb 05, 2020

BUY
$189.21 - $243.2 $2.65 Million - $3.4 Million
13,995 Added 11.3%
137,845 $32.9 Million
Q3 2019

Nov 12, 2019

BUY
$174.11 - $208.62 $1.32 Million - $1.58 Million
7,597 Added 6.53%
123,850 $24 Million
Q2 2019

Aug 08, 2019

BUY
$166.7 - $195.41 $3.43 Million - $4.02 Million
20,560 Added 21.49%
116,253 $21.4 Million
Q1 2019

Apr 26, 2019

BUY
$180.87 - $203.88 $1.47 Million - $1.66 Million
8,147 Added 9.31%
95,693 $18.2 Million
Q4 2018

Feb 08, 2019

SELL
$178.4 - $208.25 $518,252 - $604,966
-2,905 Reduced 3.21%
87,546 $16.5 Million
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $963,322 - $1.09 Million
-5,199 Reduced 5.44%
90,451 $18.8 Million
Q2 2018

Aug 09, 2018

BUY
$166.05 - $186.51 $434,552 - $488,096
2,617 Added 2.81%
95,650 $17.7 Million
Q1 2018

May 02, 2018

SELL
$169.43 - $198.0 $3.09 Million - $3.61 Million
-18,221 Reduced 16.38%
93,033 $15.9 Million
Q4 2017

Feb 06, 2018

BUY
$168.79 - $188.59 $194,277 - $217,067
1,151 Added 1.05%
111,254 $20.1 Million
Q3 2017

Nov 01, 2017

BUY
$167.29 - $191.0 $18.4 Million - $21 Million
110,103
110,103 $20.5 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.